Drugs Controller General of India approves Phase II+III trials of Oxford University vaccine by Serum Institute, Pune.

« Devastating Cost of Failure to Coordinate Economic Re-openings; Immediate need for a Coordinated Policy across States, Regions, and Nations around the world — says MIT Study. | Main | Renault DP World F1 Team makes a dramatic finish in 2020 Formula 1 Pirelli British Grand Prix, Sunday. »

August 3, 2020

Drugs Controller General of India approves Phase II+III trials of Oxford University vaccine by Serum Institute, Pune.

Oxford University

Oxford Vaccine

New Delhi, August 03, 2020. — The Drugs Controller General of India (DCGI) has allowed the Serum Institute of India, Pune, to conduct Phase II+III clinical trials of the Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD). This approval will hasten the development of the COVID-19 vaccine in India, India’s Ministry of Health and Family Welfare announced today.

Source: Ministry of Health and Family Welfare, Government of India.

|GlobalGiants.Com|

— The editor is a holder of an Oxford Alumni Card and is a member of the Oxford and Cambridge Society of India.

Edited & Posted by the Editor | 6:20 AM | Link to this Post